Exploring the consumer products news of Germany
Provided by AGP
U.S. Hits Indian Online Pharmacy Network with Visa Restrictions
(MENAFN) The United States announced visa restrictions Tuesday against 13 individuals linked to Indian online pharmacy KS International Traders, accusing them of distributing counterfeit prescription drugs laced with fentanyl to American consumers.
The US State Department identified the targeted individuals as close associates of KS International Traders and its owner, both operating out of India.
"Sanctioned online pharmacies like KS International Traders, based in India, have sold hundreds of thousands of counterfeit prescription pills laced with illicit fentanyl to unsuspecting victims across the United States," the department said in its statement.
Authorities further noted that KS International Traders generated substantial revenue through fentanyl trafficking — a drug that US President Donald Trump has formally designated a "Weapon of Mass Destruction."
The State Department framed the move as a reflection of a broader bilateral commitment, saying the action underscored the United States' and India's "enduring and shared commitment to dismantling illicit drug entities."
"Those complicit in poisoning Americans will be denied entry to the United States," it added.
The announcement signals Washington's intensifying crackdown on international networks suspected of fueling the US fentanyl crisis, with overseas-based online pharmacies emerging as a growing front in that effort.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
